Magnesium is the fourth most abundant mineral in your body, and is the reason why vegetables are green. But few people fully appreciate the importance of this miraculous mineral.
The hugely popular weight loss agent semaglutide (Ozempic, Novo Nordisk) received a pair of drug safety–related labeling additions from the US Food and Drug Administration (FDA) in late September.
Use of some antibiotic and antipsychotic drugs increases the risk of sudden cardiac arrest among people with type 2 diabetes who do not have a history of cardiovascular disease, shows the first such analysis of real-world, primary care data.
Skin reactions at insulin pump infusion sites are common among people with type 1 diabetes who use the devices and can lead to delivery failure, new research suggests.
The U.S. Food and Drug Administration said it has sent warning letters to two online vendors for selling unapproved and misbranded versions of semaglutide and tirzepatide, the active ingredients in popular diabetes and weight-loss drugs.
The US Food and Drug Administration has cleared the twiist automated insulin delivery system (Sequel Med Tech, LLC; Manchester, NH) for people aged 6 years or older with type 1 diabetes.
With continuous glucose monitors (CGMs) becoming vital tools for managing diabetes, the technology, soon to become available over the counter, is gaining popularity in off-label use to help people with obesity who may be on the verge of developing diabetes to reverse that path.